↓ Skip to main content

Lung cancer, comorbidities, and medication: the infernal trio

Overview of attention for article published in Frontiers in Pharmacology, February 2024
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age and source (69th percentile)

Mentioned by

twitter
2 X users

Readers on

mendeley
2 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Lung cancer, comorbidities, and medication: the infernal trio
Published in
Frontiers in Pharmacology, February 2024
DOI 10.3389/fphar.2023.1016976
Pubmed ID
Authors

Hélène Pluchart, Sébastien Chanoine, Denis Moro-Sibilot, Christos Chouaid, Gil Frey, Julie Villa, Bruno Degano, Matteo Giaj Levra, Pierrick Bedouch, Anne-Claire Toffart

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 2 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 2 100%

Demographic breakdown

Readers by professional status Count As %
Lecturer 1 50%
Unknown 1 50%
Readers by discipline Count As %
Arts and Humanities 1 50%
Unknown 1 50%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 February 2024.
All research outputs
#20,662,403
of 25,391,471 outputs
Outputs from Frontiers in Pharmacology
#9,962
of 19,660 outputs
Outputs of similar age
#102,705
of 150,609 outputs
Outputs of similar age from Frontiers in Pharmacology
#83
of 399 outputs
Altmetric has tracked 25,391,471 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 19,660 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.3. This one is in the 37th percentile – i.e., 37% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 150,609 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 19th percentile – i.e., 19% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 399 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 69% of its contemporaries.